Insider Buying: Ansell Limited (ASX:ANN) Insider Purchases 426 Shares of Stock

Ansell Limited (ASX:ANN) insider Debra (Debbie) Goodin acquired 426 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was acquired at an average price of A$35.10 ($22.07) per share, with a total value of A$14,952.17 ($9,403.88).

Debra (Debbie) Goodin also recently made the following trade(s):

• On Friday, February 21st, Debra (Debbie) Goodin bought 1,427 shares of Ansell stock. The shares were acquired at an average price of A$35.50 ($22.33) per share, for a total transaction of A$50,658.50 ($31,860.69).

Ansell Price Performance

The stock has a market capitalization of $3.33 billion, a PE ratio of 39.82, a PEG ratio of -14.40 and a beta of 0.46. The company has a debt-to-equity ratio of 45.24, a quick ratio of 1.13 and a current ratio of 3.84.

Ansell Increases Dividend

The business also recently announced a Interim dividend, which will be paid on Wednesday, March 5th. Stockholders of record on Wednesday, March 5th will be issued a $0.353 dividend. The ex-dividend date is Thursday, February 13th. This is a boost from Ansell’s previous Interim dividend of $0.25. This represents a dividend yield of 0.95%. Ansell’s dividend payout ratio is presently 67.06%.

About Ansell

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.